Document is current
Any future updates will be listed below
-
Authors
Tunbridge, Matthew https://orcid.org/0000-0001-8814-1008
Perkins, Griffith B.
Singer, Julian
Salehi, Tania
Ying, Tracey
Grubor-Bauk, Branka
Barry, Simon
Sim, Beatrice
Hissaria, Pravin
Chadban, Steven J.
Coates, P. Toby
- License Information
-
More Information
Article History
Received: 17 March 2022
Accepted: 4 August 2022
First Online: 15 September 2022
Declarations
:
: The study is conducted in accordance with the <i>National Statement on Ethical Conduct in Human Research</i> (2018) and the <i>CPMP/ICH Note for Guidance on Good Clinical Practice</i> and consistent with the principles that have their origin in the Declaration of Helsinki. Compliance with these standards provides assurance that the rights, safety, and well-being of trial participants are respected.Ethics approval for the RIVASTIM trials was obtained from the Central Adelaide Local Health Network (CALHN) Human Research Ethics Committee (HREC) (approval number: 2021/HRE00354) and the Sydney Local Health District (SHLD) HREC (approval numbers: X21-0411 and 2021/STE04280). Written informed consent to participate will be obtained from all participants.
: Not applicable as no identifying images, personal information, or clinical details of trial participants are presented. Informed consent materials are attached as supplementary materials.
: The authors declare that they have no competing interests.
